Biophytis Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018
Selling, General & Admin	5.49	5.49	7.24	7.15	4.02	6.59	Upgrade
Research & Development	8.85	8.85	16.03	19.67	9.92	9.09	Upgrade
Operating Expenses	14.33	14.33	23.27	26.82	13.94	15.68	Upgrade
Operating Income	-14.33	-14.33	-23.27	-26.82	-13.94	-15.68	Upgrade
Interest Expense / Income	1.63	1.63	2.56	2.52	1.53	1.5	Upgrade
Other Expense / Income	1.06	1.06	-1.62	1.83	10.04	1.85	Upgrade
Pretax Income	-17.03	-17.03	-24.22	-31.16	-25.52	-19.03	Upgrade
Income Tax	0	0	0	0	0	-0.08	Upgrade
Net Income	-17.03	-17.03	-24.22	-31.16	-25.52	-18.95	Upgrade
Shares Outstanding (Basic)	543	543	175	118	60	17	Upgrade
Shares Outstanding (Diluted)	543	543	175	118	60	17	Upgrade
Shares Change	359.13%	210.61%	47.81%	97.22%	255.24%	26.23%	Upgrade
EPS (Basic)	-120.00	-120.00	-560.00	-1040.00	-1720.00	-4480.00	Upgrade
EPS (Diluted)	-120.00	-120.00	-560.00	-1040.00	-1720.00	-4480.00	Upgrade
Free Cash Flow	-13.09	-13.09	-19.13	-24.14	-9.96	-15.33	Upgrade
Free Cash Flow Per Share	-96.44	-96.44	-437.64	-816.32	-664.08	-3632.84	Upgrade
EBITDA	-14.59	-14.59	-21.17	-28.34	-23.71	-17.27	Upgrade
Depreciation & Amortization	0.8	0.8	0.48	0.31	0.28	0.26	Upgrade
EBIT	-15.39	-15.39	-21.65	-28.65	-23.99	-17.53	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).